Relict plastidic metabolic process as a potential therapeutic target

被引:4
|
作者
Sharma, Drista [1 ]
Soni, Rani [1 ]
Rai, Praveen [1 ]
Sharma, Bhaskar [1 ]
Bhatt, Tarun Kumar [1 ]
机构
[1] Cent Univ Rajasthan, Dept Biotechnol, NH-8, Bandarsindri 305801, Rajasthan, India
关键词
METHYLERYTHRITOL PHOSPHATE-PATHWAY; FATTY-ACID BIOSYNTHESIS; 1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; CARRIER PROTEIN SYNTHASE; HUMAN MALARIA PARASITE; ENOYL-ACP REDUCTASE; PLASMODIUM-FALCIPARUM; HEME-BIOSYNTHESIS; ISOPRENOID BIOSYNTHESIS; INTRAERYTHROCYTIC STAGES;
D O I
10.1016/j.drudis.2017.09.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The alignment of the evolutionary history of parasites with that of plants provides a different panorama in the drug development process. The housing of different metabolic processes, essential for parasite survival, adds to the indispensability of the apicoplast. The different pathways responsible for fueling the apicoplast and parasite offer a myriad of proteins responsible for the apicoplast function. The studies emphasizing the target-based approaches might help in the discovery of antimalarials. The different putative drug targets and their roles are highlighted. In addition, the origin of the apicoplast and metabolic processes are reviewed and the different drugs acting upon the enzymes of the apicoplast are discussed.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [21] Duodenal Innervation and the Metabolic Syndrome: Potential Role in Pathogenesis and as a Novel Therapeutic Target
    Liu, Liansheng
    Li, Qian
    Tamrakar, Pratistha
    Sridhar, Arun
    Pasricha, Pankaj J.
    GASTROENTEROLOGY, 2016, 150 (04) : S79 - S79
  • [22] 11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome
    Joharapurkar, Amit
    Dhanesha, Nirav
    Shah, Gaurang
    Kharul, Rajendra
    Jain, Mukul
    PHARMACOLOGICAL REPORTS, 2012, 64 (05) : 1055 - 1065
  • [23] Liver X Receptors A Potential Therapeutic Target for Modulating the Atherosclerotic Process
    Parikh, Neil
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2010, 18 (06) : 269 - 274
  • [24] PPARδ as a therapeutic target in metabolic disease
    Reilly, Shannon M.
    Lee, Chih-Hao
    FEBS LETTERS, 2008, 582 (01) : 26 - 31
  • [25] The Microbiome as a Therapeutic Target for Metabolic Diseases
    Rajpal, Deepak K.
    Brown, James R.
    DRUG DEVELOPMENT RESEARCH, 2013, 74 (06) : 376 - 384
  • [26] Irisin: As a Therapeutic Target for Metabolic Disorders
    Khan, Ikram Ullah
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 8 (05) : 87 - 93
  • [27] Metabolic reprograming of cancer as a therapeutic target
    Furukawa, Tatsuhiko
    Tabata, Sho
    Minami, Kentaro
    Yamamoto, Masatatsu
    Kawahara, Kohichi
    Tanimoto, Akihide
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2023, 1867 (03):
  • [28] The immortalization process as a therapeutic target
    Stampfer, Martha R.
    Fresques, Tara
    Lee, Sun-Young
    LaBarge, Mark
    Garbe, James
    CANCER RESEARCH, 2020, 80 (16)
  • [29] Neurotensin: a potential therapeutic target
    Richelson, E
    FASEB JOURNAL, 2003, 17 (05): : A1266 - A1266
  • [30] Potential for the Microbiome as a Therapeutic Target
    Weiner, H.
    Cox, L.
    Glanz, B.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 152 - 152